Landscape Capital Management L.L.C. Purchases Shares of 912 Stryker Co. (NYSE:SYK)

Landscape Capital Management L.L.C. acquired a new position in Stryker Co. (NYSE:SYK) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 912 shares of the medical technology company’s stock, valued at approximately $328,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Annis Gardner Whiting Capital Advisors LLC raised its position in Stryker by 3.1% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 2,736 shares of the medical technology company’s stock worth $987,000 after acquiring an additional 83 shares during the period. Arete Wealth Advisors LLC increased its stake in shares of Stryker by 11.0% in the 4th quarter. Arete Wealth Advisors LLC now owns 1,204 shares of the medical technology company’s stock worth $433,000 after purchasing an additional 119 shares in the last quarter. World Investment Advisors raised its holdings in Stryker by 30.1% in the 4th quarter. World Investment Advisors now owns 10,593 shares of the medical technology company’s stock worth $3,814,000 after purchasing an additional 2,451 shares during the period. SevenBridge Financial Group LLC lifted its position in Stryker by 10.6% during the fourth quarter. SevenBridge Financial Group LLC now owns 1,496 shares of the medical technology company’s stock valued at $584,000 after purchasing an additional 143 shares in the last quarter. Finally, OneAscent Financial Services LLC bought a new stake in Stryker during the fourth quarter valued at about $475,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Activity at Stryker

In other news, Director Allan C. Golston sold 2,458 shares of Stryker stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the sale, the director now owns 14,895 shares of the company’s stock, valued at approximately $5,705,827.65. The trade was a 14.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the transaction, the director now directly owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently weighed in on SYK shares. Needham & Company LLC reaffirmed a “buy” rating and set a $442.00 price objective on shares of Stryker in a research report on Friday, March 21st. Canaccord Genuity Group upped their price target on shares of Stryker from $420.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Truist Financial increased their price objective on shares of Stryker from $409.00 to $413.00 and gave the stock a “hold” rating in a research note on Thursday, January 30th. Wells Fargo & Company upped their target price on shares of Stryker from $427.00 to $435.00 and gave the stock an “overweight” rating in a report on Wednesday, January 29th. Finally, Stifel Nicolaus raised their price target on Stryker from $400.00 to $440.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $421.90.

Stryker Price Performance

Shares of Stryker stock opened at $345.46 on Tuesday. The stock has a 50 day moving average price of $380.60 and a 200-day moving average price of $374.26. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The stock has a market cap of $131.86 billion, a price-to-earnings ratio of 44.52, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the previous year, the company posted $3.46 earnings per share. Equities analysts expect that Stryker Co. will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Monday, March 31st. Stryker’s dividend payout ratio is presently 43.30%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.